Marianne De Backer
CEO of Vir Biotechnology, a clinical-stage biopharmaceutical company focused on immune-powered medicines, discussing the company's VIR-5500 prostate cancer program and strategic partnerships.
Best podcasts with Marianne De Backer
Ranked by the Snipd community
Mar 2, 2026 • 11min
Vir Bio's Cancer Treatment Progress Driving Shares Hight
Marianne De Backer, CEO of Vir Biotechnology and leader in immune-powered medicines, talks about VIR-5500, a PSMA-targeting T‑cell engager for advanced prostate cancer. She discusses striking early trial signals, imaging-confirmed tumor responses, plans to expand into combination studies, and a strategic 50-50 partnership with Astellas to speed development.
